Smart MRI tailors cancer therapy for esophageal patients
NCT ID NCT07469241
First seen Apr 04, 2026 · Last updated Apr 27, 2026 · Updated 5 times
Summary
This study tests a personalized approach using MRI scans to guide chemotherapy and radiation, plus immunotherapy, for people with advanced esophageal cancer that cannot be removed by surgery. The goal is to see if this tailored treatment can help keep the cancer from growing for at least one year. About 50 adults aged 18-80 with this specific cancer type will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.